Pharmaceutical / Drug Definition :
Exerts vasoconstrictive action that leads to decreased edema and congestion. Also increases respiratory secretions and reduces mucus viscosity.
FDA Detentions
Guaifenesin (Guaifenesin Entry Refusal)
General U.S. Food and Drug Administration Guidelines for:
- Manufacturers Guaifenesin (Guaifenesin Suppliers)
- Processors Guaifenesin
- Repackers Guaifenesin
- Relabelers Guaifenesin
- Exporters Guaifenesin
- Importers Guaifenesin
For more information about Guaifenesin, simply click below:
U.S. FDA Regulations:
U.S. FDA Regulation: 21 C.F.R. Part 207
Registrar Corp assists businesses with U.S. FDA compliance. Certificates of Registration issued by Registrar Corp provide confirmation to industry that you are fulfilling U.S. FDA registration requirements. U.S. FDA does not issue or recognize Certificates of Registration. Registrar Corp is not affiliated with the U.S. Food and Drug Administration.
